Factors influencing plasma phenobarbitone levels in epileptic patients. 1977

M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer

1 Various statistical techniques were used to study the effects of age, sex and concurrent therapy with other anticonvulsants on the relation between plasma phenobarbitone levels and doses of (i) phenobarbtione, (ii) methylphenobarbitone or (iii) primidone, in epileptic patients. 2 Methylphenobarbitone and primidone are converted to phenobarbitone in the body. The mean doses of phenobarbitone, methylphenobarbitone and primidone which produced the same plasma phenobarbitone level (15 microgram/ml) were, respectively, 1.75,2.75 and 7.75 mg kg-1 day-1. 3 For both phenobarbitone and methylphenobarbitone dose requirement to achieve a given plasma phenobarbitone level fell progressively with age. Sex influenced the relation between plasma phenobarbitone level and phenobarbitone or methylphenobarbitone dose. Interactions were detected between primidone and both phenytoin and carbamazepine. 4 In individual patients, within the limits of dosage studied, the relation between plasma phenobarbitone level and drug dose was not rectilinear if phenobarbitone itself was taken, but was rectilinear if methylphenobarbitone was taken.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008618 Mephobarbital A barbiturate that is metabolized to PHENOBARBITAL. It has been used for similar purposes, especially in EPILEPSY, but there is no evidence mephobarbital offers any advantage over PHENOBARBITAL. Methylphenobarbital,Mebaral,Methylphenobarbitone,N-Methylphenobarbital,Prominal
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D011324 Primidone A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite. Desoxyphenobarbital,Primaclone,Apo-Primidone,Liskantin,Misodine,Mizodin,Mylepsinum,Mysoline,Primidon Holsten,Resimatil,Sertan,Apo Primidone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females

Related Publications

M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer
January 1977, Rivista di patologia nervosa e mentale,
M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer
December 1987, Critical care medicine,
M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer
January 1990, Brain & development,
M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer
January 1992, Chemical & pharmaceutical bulletin,
M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer
January 1976, Arzneimittel-Forschung,
M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer
May 1983, Boletin medico del Hospital Infantil de Mexico,
M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer
March 2000, Diabetes care,
M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer
July 1980, Pharmacology, biochemistry, and behavior,
M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer
June 2002, The Veterinary record,
M J Eadie, and C M Lander, and W D Hooper, and J H Tyrer
July 1981, British journal of clinical pharmacology,
Copied contents to your clipboard!